NGUYEN THI NGOC LAN- TAO THI MINH THUY

Size: px
Start display at page:

Download "NGUYEN THI NGOC LAN- TAO THI MINH THUY"

Transcription

1 ASSESSING THE RISK FACTORS FOR OSTEOPOROSIS AND PREDICTING FRACTURE RISK FOLLOWING FRAX MODEL IN WOMEN AGED FROM 50 YEARS AND ABOVE IN THE NORTHERN PART OF VIETNAM NGUYEN THI NGOC LAN- TAO THI MINH THUY Ha Noi Medical University 1

2 REASON FOR STUDY Osteoporosis and consequence + Decline of life quality + Increasing mobility: 20% after hip fracture + Economy damage: 17 billion USD (USA: 2005) 2

3 REASON FOR STUDY Prognostic factors of fracture + Age + Bone mineral density (BMD) + Other factors FRAX: detecting risk of fracture Vietnam: few research 3

4 OBJECTS 1/ To investigate risk factors for osteoporosis in women aged from 50 and higher in Bach Mai hospital / To predict risk of fracture by using FRAX algorithm in subjects above 4

5 OVERVIEW 1/ Giảm Definition mật độ xương of osteoporosis (WHO Tổn 1993) thương vi cấu trúc xương Britle bone Age BMD Đốt sống World Health Organization (WHO), Increase risk of fracture Ngoài đốt sống

6 OVERVIEW 2/ Bone strength: major factors Bone strength Age Bone quality Characteristic of bone mineral Mư c đô khoa ng ho a xương Micrỏarchitecture Đô da y va ca c lô hô ng ơ vo xương Sư liên kê t va đô da y cu a be xương Slide

7 OVERVIEW 3/ Bone mineral density ( T_Score) Lumbar T_score Femoral neck T_score

8 OVERVIEW 4/ Diagnosis osteoporosis Interpreting T-scores (WHO) Correlates With Lifetime Fracture Risk for Caucasian Women Osteoporosis Low Bone Mass (Osteopenia) Normal Bone Mass

9 OVERVIEW 5/ Risk factors Ten Year Fracture Probability (%) Bone Density & Age vs. Fracture Risk Age Femoral Neck T-score Probability of first fracture of hip, distal forearm, proximal humerus, and symptomatic vertebral fracture in women of Malmö, Sweden. 9 Adapted from Kanis JA

10 OVERVIEW 5/ Risk factors Prognostic factor of fracture age and BMD are not enough >50% of fractural patients have normal BMD female Male BMD T-scores:normal 55% BMD T-scores: normal 74% fracture 45% BMD T-scores -2.5 fracture 26% BMD T-scores -2.5 (Nguyen ND et al., JCEM 2007))

11 ASSESING OSTEOPOROSIS RISK FACTORS ACORRDING TO IOF 1. Have either of your parents been diagnosed with osteoporosis or broken a bone after a minor fall? 2. Have you ever broken a bone after a minor fall? 3. Have you ever taken corticosteroid for more than 3 consecutive months? 4. Have you lost more than 3 cm in height? 5. Do you regularly drink alcohol? 6. Do you currently, or have you ever, smoked >20 cigarettes per day? 7. Do you often have diarrhea For female 8. Were your ovaries removed before age Have your periods ever stopped for 12 consecutive months or more For male 10.Have you ever suffered from impotence, lack of libido ` or other symptoms related to low testosterone levels IOF, the IOF One-Minute Osteoporosis Risk Test, 11

12 1. CHẨN ĐOÁN LOÃNG XƯƠNG OVERVIEW 5/ Risk factors: FRAX model for prediction of osteoporosis fracture Age Sex Weight Height Femoral neck T_score Previous fracture 12 risk factors Rheumatoid arthritis Glucocorticoid therapy Smoking Alcohol Family s history Secondary osteoporosis FRAX (World Health Organization)

13

14 OVERVIEW 5/ Risk factors: FRAX model weight Sex age height smoking Corticoid drinking Accumulate risk factors Community health care strategy Reduce fracture rate treat RA Previous fracture Parents hip fracture Secondary osteoporosis BMDF Reduce the incidence of fracture 14

15 OVERVIEW 5/ Risk factors: FRAX model (Clinical practice guideline) Eugene McCloskey (2009), FRAX identifying people at high risk of fracture, IOF.

16 OVERVIEW 6. Research of Osteoporosis fracture * Factors that relate to osteoporosis in Viet Nam - Elderly person - Early menopause - Low body weight - Low height - Corticoid therapy - Giving birth > 2 times Vũ Thị Thanh Thủy (1998), Đỗ Thị Khánh Hỷ (2007), Mai Công Danh (2008) Viet Nam: No case-control study 16

17 OVERVIEW 6. Research of Osteoporosis fracture * Foreign study - Tamaki ( ) FRAX: Total fractures : 49,6 (6,1%) Hip fracture : 4 (0,5%) In fact :Total fracture: 43 (5,3%) Hip fracture: 8 (0.98%) - Cheung YE ( ) FRAX : valuable prognosis 17

18 SUBJECTS AND METHOD 1. Place and duration of research - Place: Rheumatology department Bach Mai hospital -Duration: 2/ / Method - Design Object 1: case-control study Object 2: cross sectional descriptive study 18

19 2. Method - Sample size + Object 1: SUBJECTS AND METHOD subjects and method 2 z 1 / n 2 [log e(1 )] P1 (1 P1 ) P2 (1 P2 ) =0,05; =0,25; P1=0,5; P2=0,2 n = 338 (169 couple : case-control) + Object 2: = 0,05; = 0,15; p = 0,3 n = 203 n Z 2 1 / 2 p(1 p) ( p ) 2 19

20 SUBJECTS AND METHOD subjects and method 2. Method - All subjects have to satisty conditions: +Female from 50 years of age +Tested BMD (on a Hologic) + Have no previous osteoporosis treatment +Accept - Study doesnot include subjects: + Having previous or current osteoporosis treatment + Loss memory + Don t accept 20

21 SUBJECTS subjects and AND method METHOD 3. Subjects Object same age couples, devided into 2 groups - Osteoporosis group + T-score -2,5 + Having previous fracture or not - Normal BMD group + T-score > - 2,5 + Having no previous fracture Object subjects were tested BMD 21

22 SUBJECTS AND METHOD 4.Data collection No Variables ( object 1) Unit Method Tool 1 age Year Ask Questionnaire 2 height Cm Ask Measurment 3 weight Kg Ask Scale 4 previous spontaneous fracture Yes/No Ask Questionnaire 5 parent s previous hip fracture Yes/No Ask/Exam Questionnaire 6 Rheumatoid arthritis Yes/No Ask/Exam Questionnaire 7 longterm of taking medicine Yes/No Ask Questionnaire 8 secondary osteoporosis Yes/No Ask Questionnaire 9 BMD T-score Testing Hologic 10 giving birth Time Ask Questionnaire 11 Age of the frist period Age Ask Questionnaire 12 age of menopause/ hysterectomy Age Ask Questionnaire 13 has stopped for > 12 month Yes/No Ask Questionnaire 14 falling Time Ask Questionnaire 22

23 SUBJECTS AND METHOD 4.Data collection No Variables ( object 1) Unit Method Tool 1 Age Year Ask Questionnaire 2 Sex Female Questionnaire 3 Height Cm Ask measurment 4 Weight Kg Ask scale 5 Previous spontaneous fracture yes/no Ask Xray 6 Parent s previous hip fracture yes/no Ask/Exam Questionnaire 7 Lngterm of glucocorticoid therapy yes/no Ask Questionnaire 8 Rheumatoid arthritis yes/no Ask/Exam Questionnaire 9 Secondary osteoporosis yes/no Ask Questionnaire 10 BMD T-score Testing Hologic 11 Drink alcohol in excess of safe drinking limits Yes/no Ask Questionnaire 12 Current smoking Yes/no Ask Questionnaire

24 SUBJECTS AND METHOD 4.Data collection 6. Research protocol 426 female 50 years of age Osteoporosis 366 women (183 couples) Normal BMD FRAX 10 year probability (%) of major osteoporotic fracture Risk factors for osteoporosis Fracture risk 24

25 RESULTS AND DISCUSSION 1. General characteristics women couples with the same age osteoporosis normal BMD - Mean age: 59,4±7, 25

26 1. general characteristics 1. General characteristics No 150,83 153,29 50,29 Physical and clinical characteristics RESULTS AND DISCUSSION Osteoporosis (n = 183) Normal bone density (n = 183) p 1 Height(cm) 150,83 ± 5,60 153,29 ± 5,45 <0,001 2 Weight(kg) 50,29 ± 8,09 55,53 ± 7,95 <0,001 3 BMI (kg/m 2 ) 20,08 ± 3,19 23,64 ± 3,24 <0,001 4 Age of first perioid 16,24 ± 2,79 16,03 ± 2,24 >0,05 5 Age of menopause 48,94 ± 4,14 51,04 ± 3,84 <0,001 6 Duration of menopause (year) 11,21 ± 8,90 9,59 ± 8,05 <0,01 7 Disease related to bone metabolism 6,6% (n = 12) 4,4% (n = 8) >0,05 8 Rheumatoid arthritis 20,8% (n = 38) 12,6% (n = 23) <0,05 9 Longterm of taking medicine* 15,8% (n = 29) 8,7% (n = 16) <0,05 26

27 RESULTS AND DISCUSSION 2. Risk factors for osteoporosis Variables (Logistic) After exclusing confounders Chi-square p Menopause occured before the age of 45 8,94 0,01 Weight 42 kg 27,635 0,001 Correlation coefficient (r) r = 0,52 p < 0,001 Exclusion of confounders 5 steps 28

28 RESULTS AND DISCUSSION 2. Fracture risk FRAX model 2.1. High rate of fracture risk Total fractures Hip fractures n % n % High risk of fracture 36 8,5 26 6,1 - Tamaki: FRAX: Total fractures: 49,6 (6,1%) Hip fractures: 4 (0,5%) In fact: Total fractures : 43 (5,3%) Hip fractures : 8 (0,98%) 29

29 RESULTS AND DISCUSSION 2 Fracture risk FRAX model 2.2. High rate of fracture risk in osteoporosis patients Total fractures Hip fractures n % n % osteoporosis 36 40, ,5 Nguyen ND (2007): osteoporosis: 45% fracture 30

30 CONCLUSIONS 1. Risk factors for osteoporosis in Vietnamese women from the age of 50 - Height <145 cm - Weight < 42 kg - BMI < 18,5 - Giving birth > 2 times - Early menopause - Duration of menopause > 5years - Age of the first period > 15 - Rheumatoid arthritis 2. High risk fracture following FRAX model - Menopause occured before the age of 45 - Weight 42 kg - 8,5% women in high risk of fracture and need to be treated to prevent fracture - 40,9% osteoporosis women in high risk of fracture and need to be taken care specially

31 RECOMMENDATIONS 1. Women above 50 need to be tested BMD 2. Well control or exclude risk factors + Weight < 42 kg + BMI < 18,5 + Giving birth > 2 times + Rheumatoid arthritis 3. Encourage using FRAX model in clinical practice in Vietnam 32

32 Thank you Thank you for your attention 33

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

LOVE YOUR BONES Protect your future

LOVE YOUR BONES Protect your future www.worldosteoporosisday.org LOVE YOUR BONES Protect your future Know your risk for osteoporosis www.iofbonehealth.org Osteoporosis is a problem worldwide, and in many countries, up to one in three women

More information

Assessment of the risk of osteoporotic fractures in Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles

Assessment of the risk of osteoporotic fractures in Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles Assessment of the risk of osteoporotic fractures in 2008 Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles Estimated lifetime fracture risk in 50-year-old white women and men Melton et al.;

More information

NICE SCOOP OF THE DAY FRAX with NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

NICE SCOOP OF THE DAY FRAX with NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield NICE SCOOP OF THE DAY FRAX with NOGG Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield Disclosures Consultant/Advisor/Speaker for: o ActiveSignal, Amgen, AstraZeneca, Consilient

More information

Using the FRAX Tool. Osteoporosis Definition

Using the FRAX Tool. Osteoporosis Definition How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX

More information

Disclosures Fractures:

Disclosures Fractures: Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Research Funding: GlaxoSmithKline, Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence

More information

Fractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases

Fractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases Financial Disclosures Fractures: Epidemiology and Risk Factors Research grants, speaking or consulting: Amgen, Lilly, Merck, Novartis, Radius Dennis M. Black, PhD Department of Epidemiology and Biostatistics

More information

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis

More information

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster DOI 10.1007/s00296-012-2460-y ORIGINAL ARTICLE Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security

More information

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction Asian Spine Journal Asian Spine Clinical Journal Study Asian Spine J 2014;8(6):729-734 High http://dx.doi.org/10.4184/asj.2014.8.6.729 risk patients with osteopenia How Many High Risk Korean Patients with

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Osteoporosis- Do We Need to Think Beyond Bone Mineral Density? Dr Preeti Soni 1, Dr Shipra

More information

International Journal of Research and Review E-ISSN: ; P-ISSN:

International Journal of Research and Review   E-ISSN: ; P-ISSN: International Journal of Research and Review www.gkpublication.in E-ISSN: 2349-9788; P-ISSN: 2454-2237 Original Research Article Risk Assessment of Osteoporosis in Postmenopausal Women Dr Savita Tamaria

More information

FRAX Based Guidelines: Is a Universal Model Appropriate?

FRAX Based Guidelines: Is a Universal Model Appropriate? FRAX Based Guidelines: Is a Universal Model Appropriate? Marlene Chakhtoura, MD Research Fellow Calcium Metabolism & Osteoporosis Program WHO Collaborating Center for Metabolic Bone Disorders American

More information

Osteoporosis/Fracture Prevention

Osteoporosis/Fracture Prevention Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team

More information

Official Positions on FRAX

Official Positions on FRAX 196 96 DEPLIANT 3,5x8,5.indd 1 2010 Official Positions on FRAX 21.03.11 11:45 Interpretation and Use of FRAX in Clinical Practice from the International Society for Clinical Densitometry and International

More information

Case Finding and Risk Assessment for Osteoporosis

Case Finding and Risk Assessment for Osteoporosis Case Finding and Risk Assessment for Osteoporosis Patient may present as a fragility fracture or risk fracture Fragility fracture age 50 Clinical risk factors aged 50 Very strong clinical risk factors

More information

A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model

A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model J Bone Metab 15;:113-11 http://dx.doi.org/.15/jbm.15..3.113 pissn 7-375 eissn 7-79 Original Article A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model

More information

Osteoporosis challenges

Osteoporosis challenges Osteoporosis challenges Osteoporosis challenges Who should have a fracture risk assessment? Who to treat? Drugs, holidays and unusual adverse effects Fracture liaison service? The size of the problem 1

More information

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.

More information

Screening for absolute fracture risk using FRAX tool in men and women within years in urban population of Puducherry, India

Screening for absolute fracture risk using FRAX tool in men and women within years in urban population of Puducherry, India International Journal of Research in Orthopaedics Firoz A et al. Int J Res Orthop. 217 Sep;3(5):151-156 http://www.ijoro.org Original Research Article DOI: http://dx.doi.org/1.1823/issn.2455-451.intjresorthop21739

More information

Osteoporosis Screening and Treatment in Type 2 Diabetes

Osteoporosis Screening and Treatment in Type 2 Diabetes Osteoporosis Screening and Treatment in Type 2 Diabetes Ann Schwartz, PhD! Dept. of Epidemiology and Biostatistics! University of California San Francisco! October 2011! Presenter Disclosure Information

More information

Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck

Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence and impact of fractures

More information

Download slides:

Download slides: Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division

More information

Australian Journal of Basic and Applied Sciences

Australian Journal of Basic and Applied Sciences AENSI Journals Australian Journal of Basic and Applied Sciences ISSN:1991-8178 Journal home page: www.ajbasweb.com Fracture Assessment tool of Osteoporotic (FRAX) Fractures with bone Mineral Density (BMD)

More information

Management of postmenopausal osteoporosis

Management of postmenopausal osteoporosis Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,

More information

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11. NIH Public Access Author Manuscript Published in final edited form as: Endocr Pract. 2013 ; 19(5): 780 784. doi:10.4158/ep12416.or. FRAX Prediction Without BMD for Assessment of Osteoporotic Fracture Risk

More information

Fractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009

Fractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009 Fractures: Epidemiology and Risk Factors Mary L. Bouxsein, PhD Department of Orthopaedic Surgery Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA Outline Fracture incidence and impact

More information

Osteoporosis Management

Osteoporosis Management Osteoporosis Management Lisa Voss PA C, CCD Laura Frontiero NP C, CCD Kaiser Healthy Bones Program San Diego Disclosures: Nothing to disclose www.zazzle.com 1 Overview How to diagnose Osteoporosis FRAX

More information

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT Original Article Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT Objective: To compare Fracture Risk Assessment Tool (FRAX) calculations with and without bone

More information

An audit of osteoporotic patients in an Australian general practice

An audit of osteoporotic patients in an Australian general practice professional Darren Parker An audit of osteoporotic patients in an Australian general practice Background Osteoporosis is a major contributor to morbidity and mortality in Australia, and is predicted to

More information

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits

More information

Study of secondary causes of male osteoporosis

Study of secondary causes of male osteoporosis Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos

More information

Available online at ScienceDirect. Osteoporosis and Sarcopenia 1 (2015) 109e114. Original article

Available online at  ScienceDirect. Osteoporosis and Sarcopenia 1 (2015) 109e114. Original article HOSTED BY Available online at www.sciencedirect.com ScienceDirect Osteoporosis and Sarcopenia 1 (2015) 109e114 Original article Localized femoral BMD T-scores according to the fracture site of hip and

More information

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK nogg NATIONAL OSTEOPOROSIS GUIDELINE GROUP Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK Produced by J Compston, A Cooper,

More information

Clinician s Guide to Prevention and Treatment of Osteoporosis

Clinician s Guide to Prevention and Treatment of Osteoporosis Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening

More information

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one

More information

Beyond the T-score: New Thinking in Osteoporosis 2

Beyond the T-score: New Thinking in Osteoporosis 2 Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/beyond-the-t-score-new-thinking-in-osteoporosis-

More information

Coordinator of Post Professional Programs Texas Woman's University 1

Coordinator of Post Professional Programs Texas Woman's University 1 OSTEOPOROSIS Update 2007-2008 April 26, 2008 How much of our BMD is under our control (vs. genetics)? 1 2 Genetic effects on bone loss: longitudinal twin study (Makovey, 2007) Peak BMD is under genetic

More information

Osteoporosis. Overview

Osteoporosis. Overview v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)

More information

Disclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014

Disclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014 Disclosures Diagnostic Challenges in Osteoporosis: Whom To Treat Ethel S. Siris, MD Columbia University Medical Center New York, NY Consultant on scientific issues for: AgNovos Amgen Eli Lilly Merck Novartis

More information

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008 BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology

More information

Closing the Care Gap in Osteoporosis ICE Conference 2015

Closing the Care Gap in Osteoporosis ICE Conference 2015 Closing the Care Gap in Osteoporosis ICE Conference 2015 Pat McCarthy-Briggs RD, MHEd Thank You! What is osteoporosis? a systemic skeletal disease characterized by low bone mass and microarchitectural

More information

Osteoporotic Fracture Risk Assessment Using Bone Mineral Density in Korean: A Community-based Cohort Study

Osteoporotic Fracture Risk Assessment Using Bone Mineral Density in Korean: A Community-based Cohort Study J Bone Metab 2016;23:34-39 http://dx.doi.org/10.11005/jbm.2016.23.1.34 pissn 2287-6375 eissn 2287-7029 Original Article Osteoporotic Fracture Risk Assessment Using Bone Mineral Density in Korean: A Community-based

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: : assessing the risk of fragility fracture bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new

More information

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA ORIGINAL ARTICLE Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA Leila Amiri 1, Azita Kheiltash 2, Shafieh Movassaghi 1, Maryam Moghaddassi 1, and Leila Seddigh 2 1 Rheumatology

More information

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Use of DXA / Bone Density in the Care of Your Patients Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Important Websites Resources for Clinicians and Patients www.nof.org www.iofbonehealth.org

More information

Trabecular Bone Score (TBS)

Trabecular Bone Score (TBS) Trabecular Bone Score (TBS) From fracture prediction to clinical use Teheran May 2016 Prof. Didier Hans Center for Bone diseases, DAL Lausanne University Hospital, Switzerland didier.hans@ascendys.ch Osteoporosis

More information

Make your. first break. your last.

Make your. first break. your last. www.iofbonehealth.org Make your first break your last WHAT IS OSTEOPOROSIS? Osteoporosis is a disease in which bones become more fragile and weak, leading to an increased risk of fractures (broken bones).

More information

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone

More information

1

1 www.osteoporosis.ca 1 2 Overview of the Presentation Osteoporosis: An Overview Bone Basics Diagnosis of Osteoporosis Drug Therapies Risk Reduction Living with Osteoporosis 3 What is Osteoporosis? Osteoporosis:

More information

Osteoporosis Clinical Guideline. Rheumatology January 2017

Osteoporosis Clinical Guideline. Rheumatology January 2017 Osteoporosis Clinical Guideline Rheumatology January 2017 Introduction Osteoporosis is a condition of low bone mass leading to an increased risk of low trauma fractures. The prevalence of osteoporosis

More information

FRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

FRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield FRAX, NICE and NOGG Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield Disclosures Research funding and/or honoraria and/or advisory boards for: o ActiveSignal, Amgen, Bayer, Boehringer

More information

Osteoporosis in Men Wendy Rosenthal PharmD. This program has been brought to you by PharmCon

Osteoporosis in Men Wendy Rosenthal PharmD. This program has been brought to you by PharmCon Osteoporosis in Men Wendy Rosenthal PharmD This program has been brought to you by PharmCon Osteoporosis in Men Speaker: Dr. Wendy Rosenthal, President of MedOutcomes, will be the presenter for this webcast.

More information

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi Clinical Utility of Bone Densitometry Diagnosis (DXA)

More information

Preoperative dual-energy X-ray absorptiometry and FRAX in patients with lumbar spinal stenosis

Preoperative dual-energy X-ray absorptiometry and FRAX in patients with lumbar spinal stenosis Bergh et al. Journal of Orthopaedic Surgery and Research (2018) 13:253 https://doi.org/10.1186/s13018-018-0964-1 RESEARCH ARTICLE Preoperative dual-energy X-ray absorptiometry and FRAX in patients with

More information

Assessment of Individual Fracture Risk: FRAX and Beyond

Assessment of Individual Fracture Risk: FRAX and Beyond Curr Osteoporos Rep (2010) 8:131 137 DOI 10.1007/s11914-010-0022-3 Assessment of Individual Fracture Risk: FRAX and Beyond Joop P. W. van den Bergh & Tineke A. C. M. van Geel & Willem F. Lems & Piet P.

More information

RESEARCH. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores

RESEARCH. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores Julia Hippisley-Cox, professor of clinical epidemiology and general

More information

2017 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media,

2017 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, 2017 IEEE. Personal use of this material is permitted. Permission from IEEE must be obtained for all other uses, in any current or future media, including reprinting/republishing this material for advertising

More information

PERSPECTIVES KIDNEY TRANSPLANTATION IN VIET NAM From Dream to Reality

PERSPECTIVES KIDNEY TRANSPLANTATION IN VIET NAM From Dream to Reality PERSPECTIVES KIDNEY TRANSPLANTATION IN VIET NAM From Dream to Reality Tran Ngoc Sinh* Pham Gia Khanh** Vietnam Society of Organ Transplantation (VSOT) * Vice-President of VSOT; HCMC University of Medicine

More information

What Is FRAX & How Can I Use It?

What Is FRAX & How Can I Use It? What Is FRAX & How Can I Use It? Jacqueline Osborne PT, DPT Board Certified Geriatric Clinical Specialist Certified Exercise Expert for the Aging Adult Brooks Rehabilitation; Jacksonville, FL Florida Physical

More information

All about. Osteoporosis

All about. Osteoporosis All about Osteoporosis What is osteoporosis? Osteoporosis literally means porous bone. It is a condition that causes bones to become thin and fragile, decreasing bone strength and making them more prone

More information

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India International Journal of Public Health Science (IJPHS) Vol.3, No.4, December 2014, pp. 276 ~ 280 ISSN: 2252-8806 276 Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

More information

FRAX Identifying people at high risk of fracture

FRAX Identifying people at high risk of fracture FRAX Identifying people at high risk of fracture WHO Fracture Risk Assessment Tool, a new clinical tool for informed treatment decisions Authored by Dr. Eugene McCloskey International Osteoporosis Foundation

More information

Research Article Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort

Research Article Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort International Journal of Endocrinology Volume 2013, Article ID 715025, 9 pages http://dx.doi.org/10.1155/2013/715025 Research Article Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled

More information

Osteoporosis. Open Access. John A. Kanis. Diseases, University of Sheffield, UK

Osteoporosis. Open Access. John A. Kanis. Diseases, University of Sheffield, UK Journal of Medical Sciences (2010); 3(3): 00-00 Review Article Osteoporosis Open Access John A. Kanis WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK incorporated into

More information

John J. Wolf, DO Family Medicine

John J. Wolf, DO Family Medicine John J. Wolf, DO Family Medicine Objectives: 1. Review incidence & Risk of Osteoporosis 2.Review indications for testing 3.Review current pharmacologic & Non pharmacologic Tx options 4.Understand & Utilize

More information

July 2012 CME (35 minutes) 7/12/2016

July 2012 CME (35 minutes) 7/12/2016 Financial Disclosures Epidemiology and Consequences of Fractures Advisory Board: Amgen Janssen Pharmaceuticals Inc. Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Osteoporotic

More information

Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study

Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study Heikki Kröger Kuopio Musculoskeletal Research Unit, University of Eastern Finland (UEF) Dept. of Orthopaedics, Traumatology

More information

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS

Osteoporosis: An Overview. Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Objectives Review osteoporosis

More information

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

Skeletal Manifestations

Skeletal Manifestations Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes

More information

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS 4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending

More information

A JOINT INITIATIVE FOR FRACTURE PREVENTION. Know Your Bones Community Risk Report October 2018

A JOINT INITIATIVE FOR FRACTURE PREVENTION. Know Your Bones Community Risk Report October 2018 A JOINT INITIATIVE FOR FRACTURE PREVENTION Forewords Greg Lyubomirsky CEO Osteoporosis Australia 1 Know Your Bones was developed to help Australians understand their risk of poor bone health and discuss

More information

Validation of the Osteoporosis Self-Assessment Tool in US Male Veterans

Validation of the Osteoporosis Self-Assessment Tool in US Male Veterans Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health, vol. 17, no. 1, 32e37, 2014 Published by Elsevier Inc. on behalf of The International Society for Clinical Densitometry

More information

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men Osteoporos Int (1999) 10:265 270 ß 1999 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Bone Mineral Density and Vertebral Fractures

More information

Evaluation of FRAX to characterise fracture risk in Poland

Evaluation of FRAX to characterise fracture risk in Poland DOI 1.17/s198-1-152- ORIGINAL ARTICLE Evaluation of FRAX to characterise fracture risk in Poland E. Czerwinski & J. A. Kanis & J. Osieleniec & A. Kumorek & A. Milert & H. Johansson & E. V. McCloskey &

More information

New Osteoporosis Guidelines: What you and your health provider need to know QUESTION & ANSWER

New Osteoporosis Guidelines: What you and your health provider need to know QUESTION & ANSWER The first of the newsletters on these Qs and As should include a refresher on the Virtual Forums what they are, how they work, etc. The fact is that less than 5% of COPN members tune in for any given Forum.

More information

ESTIMATION OF RISK IN THE FIELD OF OSTEOPOROSIS

ESTIMATION OF RISK IN THE FIELD OF OSTEOPOROSIS ESTIMATION OF RISK IN THE FIELD OF OSTEOPOROSIS Helena Johansson UNIVERSITY OF GOTHENBURG Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 2011 1 2 ESTIMATION

More information

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis BONE HEALTH Dr. Tia Lillie Exercise, Physical Activity and Osteoporosis Food for thought... How old would you be if you didn t know how old you were? DEFINITION: Osteoporosis Osteoporosis (OP) is a disease

More information

Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014

Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays. Suzanne Morin MD FRCP FACP McGill University May 2014 Treatments for Osteoporosis Expected Benefits, Potential Harms and Drug Holidays Suzanne Morin MD FRCP FACP McGill University May 2014 Learning Objectives Overview of osteoporosis management Outline efficacy

More information

Osteoporosis: A Tale of 3 Task Forces!

Osteoporosis: A Tale of 3 Task Forces! Osteoporosis: A Tale of 3 Task Forces! Robert A. Adler, MD McGuire Veterans Affairs Medical Center Virginia Commonwealth University Richmond, Virginia, USA Disclosures The opinions are those of the speaker

More information

Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey

Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey ORIGINAL doi:10.1507/endocrj.ej17-0331 Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey Rena Oka 1), 2), Masahiro

More information

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017 COPD-Related Musculoskeletal Disease Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017 A 60-year old man with COPD comes into your office for a routine office visit. He is a former

More information

Understanding the Development of Osteoporosis and Preventing Fractures: WHO Do We Treat Now?

Understanding the Development of Osteoporosis and Preventing Fractures: WHO Do We Treat Now? Understanding the Development of Osteoporosis and Preventing Fractures: WHO Do We Treat Now? Steven M. Petak, MD, JD, FACE, FCLM Texas Institute for Reproductive Medicine And Endocrinology, Houston, Texas

More information

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance Osteoporosis: fragility fracture risk Costing report Implementing NICE guidance August 2012 NICE clinical guideline 146 1 of 15 This costing report accompanies the clinical guideline: Osteoporosis: assessing

More information

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Dumfries and Galloway. Treatment Protocol for Osteoporosis Dumfries and Galloway Treatment Protocol for Osteoporosis DIAGNOSIS OF OSTEOPOROSIS 2 Diagnostic Criteria 2 Multiple low trauma vertebral fractures in the absence of myeloma or metastatic disease. 2 T-score

More information

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Definition. Presenter Disclosure Information.

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Definition. Presenter Disclosure Information. 4 4:45 pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn

More information

8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview

8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview Disclosure Glucocorticoid induced osteoporosis: overlooked and undertreated? I have no financial disclosure relevant to this presentation Tasma Harindhanavudhi, MD Division of Diabetes and Endocrinology

More information

Preventive Care Risk Assessment

Preventive Care Risk Assessment Preventive Care Risk Assessment Name: DOB Date Lung Cancer (please check all that apply) You currently smoke cigarettes, cigars, or pipes. You have a history of second-hand smoke exposure. You have been

More information

Epidemiology and Consequences of Fractures

Epidemiology and Consequences of Fractures Epidemiology and Consequences of Fractures Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Financial Disclosures Advisory Board: Amgen Research Support: Hologic 24July12 1 Outline

More information

Screening points for a peripheral densitometer of the calcaneum for the diagnosis of osteoporosis

Screening points for a peripheral densitometer of the calcaneum for the diagnosis of osteoporosis 23 Ivorra Cortés J, Román-Ivorra JA, Alegre Sancho JJ, Beltrán Catalán E, Chalmeta Verdejo I, Fernández-Llanio Comella N, Muñoz Gil S Servicio de Reumatología - Hospital Universitario Dr. Peset - Valencia

More information

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS Wednesday, December 1, 2010 1:00 p.m. to 2:00 p.m. ET 1. I m 55 years old. I ve been taking Fosavance

More information

Osteoporosis. Treatment of a Silently Developing Disease

Osteoporosis. Treatment of a Silently Developing Disease Osteoporosis Treatment of a Silently Developing Disease Marc K. Drezner, MD Senior Associate Dean Emeritus Professor of Medicine Emeritus University of Wisconsin-Madison Auditorium The Forest at Duke October

More information

Risk factors associated with low bone mineral density in Ajman, UAE

Risk factors associated with low bone mineral density in Ajman, UAE Risk factors associated with low bone mineral density in Ajman, UAE Tarek Fawsy 1, Jayadevan Sreedharan 2*, Jayakumary Muttappallymyalil 2, Salma Obaid Saeed Alshamsi 2, Mariyam Saif Salim Humaid Bin Bader

More information

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329 Horizon Scanning Centre March 2014 Denosumab for glucocorticoidinduced osteoporosis SUMMARY NIHR HSC ID: 6329 This briefing is based on information available at the time of research and a limited literature

More information

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Dumfries and Galloway. Treatment Protocol for Osteoporosis Dumfries and Galloway Treatment Protocol for Osteoporosis DIAGNOSIS OF OSTEOPOROSIS 2 Diagnostic Criteria 2 REFERRAL CRITERIA FOR DEXA 3 TREATMENT 4 Non-Drug Therapy : for all 4 Non-Drug Therapy : in the

More information

Pharmacy Management Drug Policy

Pharmacy Management Drug Policy SUBJECT: - Forteo (teriparatide), Prolia (denosumab), Tymlos (abaloparatide) POLICY NUMBER: Pharmacy-35 EFFECTIVE DATE: 9/07 LAST REVIEW DATE: 9/29/2017 If the member s subscriber contract excludes coverage

More information

Nurse to Nurse Hospital or Hiking: You choose

Nurse to Nurse Hospital or Hiking: You choose Nurse to Nurse Hospital or Hiking: You choose 24TH BIENNIAL PRNABC CONFERENCE GWEN ELLERT, MEd, RN HEALTH CARE EDUCATOR TRELLE ENTERPRISES INC. MAY 8, 2014 You will learn Osteoarthritis (OA): how to assess

More information

Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen

Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen Diagnostische Präzision von DXL im Vergleich zu DXA bei pmp Frauen mit Frakturen Christian Muschitz II. Medizinische Abteilung mit Rheumatologie, Osteologie & Gastroenterologie Akademisches Lehrkrankenhaus

More information

Case identification of patients at risk for an osteoporotic fracture

Case identification of patients at risk for an osteoporotic fracture Identifying Patients With Osteoporosis or at Risk for Osteoporotic Fractures Yong Chen, MD, PhD; Leslie R. Harrold, MD, MPH; Robert A. Yood, MD; Terry S. Field, DSc; and Becky A. Briesacher, PhD Case identification

More information